IL112963A - Pharmaceutical composition containing gamma globulins or fragments - Google Patents

Pharmaceutical composition containing gamma globulins or fragments

Info

Publication number
IL112963A
IL112963A IL11296395A IL11296395A IL112963A IL 112963 A IL112963 A IL 112963A IL 11296395 A IL11296395 A IL 11296395A IL 11296395 A IL11296395 A IL 11296395A IL 112963 A IL112963 A IL 112963A
Authority
IL
Israel
Prior art keywords
preparation
fragments
methods
pharmaceutical composition
composition containing
Prior art date
Application number
IL11296395A
Other languages
English (en)
Other versions
IL112963A0 (en
Original Assignee
Arp Biomed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26907064&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL112963(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Arp Biomed Ltd filed Critical Arp Biomed Ltd
Publication of IL112963A0 publication Critical patent/IL112963A0/xx
Publication of IL112963A publication Critical patent/IL112963A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL11296395A 1994-03-14 1995-03-12 Pharmaceutical composition containing gamma globulins or fragments IL112963A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21236194A 1994-03-14 1994-03-14
US08/340,094 US5562902A (en) 1994-03-14 1994-11-15 Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin

Publications (2)

Publication Number Publication Date
IL112963A0 IL112963A0 (en) 1995-06-29
IL112963A true IL112963A (en) 2000-02-17

Family

ID=26907064

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11296395A IL112963A (en) 1994-03-14 1995-03-12 Pharmaceutical composition containing gamma globulins or fragments

Country Status (20)

Country Link
US (2) US5562902A (xx)
EP (1) EP0750514B1 (xx)
JP (2) JP4004062B2 (xx)
KR (1) KR100352583B1 (xx)
CN (1) CN1089007C (xx)
AT (1) ATE198711T1 (xx)
AU (1) AU700751B2 (xx)
BR (1) BR9507067A (xx)
CA (1) CA2184269A1 (xx)
DE (1) DE69519924T2 (xx)
DK (1) DK0750514T3 (xx)
ES (1) ES2155519T3 (xx)
FI (1) FI114011B (xx)
GR (1) GR3035758T3 (xx)
HK (1) HK1014493A1 (xx)
IL (1) IL112963A (xx)
NZ (1) NZ282659A (xx)
PT (1) PT750514E (xx)
TW (1) TW418091B (xx)
WO (1) WO1995024927A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080050390A1 (en) * 1994-03-14 2008-02-28 Yehuda Shoenfeld Administration of gamma globulins to treat metastatic melanoma
US20070166313A1 (en) * 1994-03-14 2007-07-19 Yehuda Shoenfeld Administration of gamma globulins to treat cancer
CA2331738A1 (en) 1998-05-07 1999-11-11 Research Corporation Technologies, Inc. Oral administration of immunoglobulins for treating autoimmune hearing loss
TWI248819B (en) * 1999-09-27 2006-02-11 Arp Biomed Ltd Pharmaceutical composition containing IVIG for use in treating lymphoma
EP1267905B1 (en) * 2000-03-10 2005-09-28 Medinnova As Composition for the treatment of heart failure
AT410637B (de) * 2001-06-01 2003-06-25 Igeneon Krebs Immuntherapie Verwendung von polyklonalen immunglobulinen
CA2474405A1 (en) 2002-02-15 2003-08-21 Richard Brunner Medicament for the treatment of choroidal neovascularisation
US20080031903A1 (en) * 2006-07-27 2008-02-07 Andrea Gambotto Method of treating ocular infections
WO2008137159A1 (en) * 2007-05-07 2008-11-13 Gammacan Human anti-vegf polyclonal antibodies and uses thereof
WO2010093606A1 (en) * 2009-02-11 2010-08-19 Martin Heath Bluth Reciprocal serum/plasma exchange for the treatment of cancer
CN114129722B (zh) * 2020-09-04 2024-04-05 中国医学科学院输血研究所 注射用人免疫球蛋白在制备预防或治疗辐照损伤的药物中的用途
CN114392351B (zh) * 2021-07-13 2024-04-05 中国医学科学院放射医学研究所 毛螺菌科细菌与注射用人免疫球蛋白的联合用药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699783A (en) * 1983-03-11 1987-10-13 Terman David S Products and methods for treatment of cancer
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
US4699784A (en) * 1986-02-25 1987-10-13 Center For Molecular Medicine & Immunology Tumoricidal methotrexate-antibody conjugate
TWI248819B (en) * 1999-09-27 2006-02-11 Arp Biomed Ltd Pharmaceutical composition containing IVIG for use in treating lymphoma

Also Published As

Publication number Publication date
GR3035758T3 (en) 2001-07-31
IL112963A0 (en) 1995-06-29
AU1984895A (en) 1995-10-03
JP2007119493A (ja) 2007-05-17
HK1014493A1 (en) 1999-09-30
PT750514E (pt) 2001-06-29
EP0750514A1 (en) 1997-01-02
NZ282659A (en) 1998-06-26
KR100352583B1 (ko) 2002-12-26
US5562902A (en) 1996-10-08
ATE198711T1 (de) 2001-02-15
BR9507067A (pt) 1997-09-30
FI963598A0 (fi) 1996-09-12
CN1148343A (zh) 1997-04-23
AU700751B2 (en) 1999-01-14
US5965130A (en) 1999-10-12
DK0750514T3 (da) 2001-05-21
DE69519924D1 (de) 2001-02-22
CN1089007C (zh) 2002-08-14
TW418091B (en) 2001-01-11
JP4004062B2 (ja) 2007-11-07
WO1995024927A1 (en) 1995-09-21
FI114011B (fi) 2004-07-30
JPH09512791A (ja) 1997-12-22
DE69519924T2 (de) 2001-08-23
CA2184269A1 (en) 1995-09-21
ES2155519T3 (es) 2001-05-16
EP0750514B1 (en) 2001-01-17
FI963598A (fi) 1996-09-12

Similar Documents

Publication Publication Date Title
MY112405A (en) Method of tumer treatment.
GR3032511T3 (en) Combination with anti-hormonal compounds and binding molecules for the treatment of cancer.
IL112963A (en) Pharmaceutical composition containing gamma globulins or fragments
HK1046093A1 (en) Docetaxel in combination with rhumab her2 for the treatment of cancers.
DE69320646D1 (de) Verfahren zur behandlung von krebs durch kombinationstherapie mit 2'-halomethylidenderivaten und einem s- oder m-phase spezifischen antineoplastischen wirkstoff
PT944389E (pt) Composições purificadas de 10-propargil-10-desaza-aminopterina e métodos para a sua utilização no tratamento de tumores
GB8805792D0 (en) Medicaments
IL141550A0 (en) Methods and compositions for the prevention or treatment of cancer
EP0527852B2 (en) Method and compositions for treating injury
WO2000006136A3 (en) Therapeutic combination of polyamine with an anticancer agent
BR9808263A (pt) Processos para tratar câncer em um humano em necessidade de tratamento e para manufaturar um medicamento para inibir o crescimento em um humano de um tumor sólido, e, uso de um composto.
HK1049608A1 (zh) 丙種球蛋白的投藥治療淋巴瘤
MD798G2 (ro) Metoda de tratament a cancerului mamar
EP1234585A3 (en) Methods and compositions for the prevention or treatment of cancer
DE59506911D1 (de) Verwendung von intravenös applizierbarem eisen zur therapie von tumorerkrankungen und/oder infektionskrankheiten
GB2233559A (en) Antibodies for use in antilymphocyte antibody therapy
RU97114158A (ru) Способ лечения злокачественных опухолей

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees